Vaccine firm will get $400,000 from Indiana Seed Fund

Bioscience Vaccines will receive an investment of $400,000 from the Indiana Seed Fund, which was set up by BioCrossroads to help life sciences firms. Bioscience plans to put the money toward a technology that can be used to develop adjuvants, which can boost the efficacy of vaccines.

View Full Article in:

Indianapolis Star (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC
Food Lawyer
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Meridian Health Plan
Detroit, MI